Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 24 Jan 2022 |
2 | Reply to Exam Report (MIS-R) | 22 Mar 2022 |
3 | Authorization Letter | 10 Jul 2023 |
4 | Documents in support of Show cause Hearing (SCH) | 14 Jul 2023 |
5 | Authorization Letter | 13 Feb 2024 |
6 | Documents in support of Show cause Hearing (SCH) | 14 Feb 2024 |
7 | Authorization Letter | 17 Jun 2024 |
8 | Authorization Letter | 14 Oct 2024 |
1 | EXAMINATION REPORT | 13090857 | 28 Feb 2022 | |
2 | Hearing Notice (Show Cause) | 15413270 | 13 Jun 2023 | |
3 | Hearing Notice (Show Cause) | 17329453 | 07 Feb 2024 | |
4 | Hearing Notice (Show Cause) | 18128586 | 09 May 2024 | |
5 | Hearing Notice (Show Cause) | 18822400 | 09 Sep 2024 | |
6 | Adjourned Notice | 18991102 | 14 Oct 2024 |
Combiart was applied on 24 January 2022.
Trademark application was filed by STRIDES PHARMA SCIENCE.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Objected.
Listed application Id of Combiart is 5297493.
Trademark attorney of the Combiart is Altacit Global.
Combiart is a WORD as per IP India data.